Fluxion Biosciences

About:

Fluxion Biosciences is engaged in the research and development of cellular analysis tools and drug discovery applications.

Website: http://www.fluxionbio.com

Twitter/X: fluxionbio

Top Investors: National Institutes of Health, Life Science Angels, Signet Healthcare Partners, Kodiak Venture Partners, Claremont Creek Ventures

Description:

Fluxion Biosciences was formed in 2005 to address critical needs for cellular analysis tools in the pharmaceutical, biotech and research industries. The company has developed a proprietary microfluidic platform which enables precise cellular manipulation, rapid low-volume compound addition, environmental control and software-based data acquisition.

Total Funding Amount:

$22.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Alameda, California, United States

Founded Date:

2005-01-01

Contact Email:

info(AT)fluxionbio.com

Founders:

Cristian Ionescu Zanetti, Michael Schwartz

Number of Employees:

11-50

Last Funding Date:

2019-10-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai